Huaxin Hou

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Compound 4a induces paraptosis in liver cancer through endoplasmic reticulum stress mediated by the calreticulin protein.

Compound 4a induces paraptosis in liver cancer through endoplasmic reticulum stress mediated by the calreticulin protein.

Journal: British journal of pharmacology

Published: March 06, 2024

The anthraquinone derivative KA-4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin.

The anthraquinone derivative KA-4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin.

Journal: Molecular carcinogenesis

Published: February 12, 2024

Novel anthraquinone derivatives trigger endoplasmic reticulum stress response and induce apoptosis.

Novel anthraquinone derivatives trigger endoplasmic reticulum stress response and induce apoptosis.

Journal: Future medicinal chemistry

Published: February 17, 2023

Quantitative Proteomics Based on iTRAQ Reveal that Nitidine Chloride Induces Apoptosis by Activating JNK/c-Jun Signaling in Hepatocellular Carcinoma Cells.

Quantitative Proteomics Based on iTRAQ Reveal that Nitidine Chloride Induces Apoptosis by Activating JNK/c-Jun Signaling in Hepatocellular Carcinoma Cells.

Journal: Planta medica

Published: February 01, 2022

Constraction of triple negative breast cancer cell model containing EGFR promoter and luciferase reporter gene

Constraction of triple negative breast cancer cell model containing EGFR promoter and luciferase reporter gene

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: November 05, 2020

A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.

A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.

Journal: International journal of oncology

Published: August 30, 2020

Novel anthraquinone compounds as anticancer agents and their potential mechanism.

Novel anthraquinone compounds as anticancer agents and their potential mechanism.

Journal: Future medicinal chemistry

Published: March 17, 2020

Rhein Derivative 4F Inhibits the Malignant Phenotype of Breast Cancer by Downregulating Rac1 Protein.

Rhein Derivative 4F Inhibits the Malignant Phenotype of Breast Cancer by Downregulating Rac1 Protein.

Journal: Frontiers in pharmacology

Published: January 19, 2020

Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates.

Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates.

Journal: Future medicinal chemistry

Published: November 14, 2019

An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F.

An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F.

Journal: Anti-cancer drugs

Published: July 06, 2019

Novel Anthraquinone Compounds Induce Cancer Cell Death through Paraptosis.

Novel Anthraquinone Compounds Induce Cancer Cell Death through Paraptosis.

Journal: ACS medicinal chemistry letters

Published: December 10, 2018

A novel Rhein derivative: Activation of Rac1/NADPH pathway enhances sensitivity of nasopharyngeal carcinoma cells to radiotherapy.

A novel Rhein derivative: Activation of Rac1/NADPH pathway enhances sensitivity of nasopharyngeal carcinoma cells to radiotherapy.

Journal: Cellular signalling

Published: August 18, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026